Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2019-02-13 | 2020-08-10 | 75632 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2017-05-24 | 2017-07-19 | 11053 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2017-08-08 | 2017-09-22 | 18567 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2023-09-07 | 2023-12-22 | 203843 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2023-09-15 | 2023-12-22 | 204417 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2023-12-01 | 2024-01-05 | 212377 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-11-16 | 2019-01-17 | 67034 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2022-04-08 | 2022-06-12 | 158373 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2022-07-22 | 2022-09-01 | 165335 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2022-10-21 | 2023-01-06 | 172347 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2023-05-26 | 2023-06-16 | 193212 |
| APO-TERIFLUNOMIDE | 14MG | TABLET | Resolved | 2023-10-27 | 2024-01-12 | 208385 |
| APO-TERIPARATIDE INJECTION | 250MCG | SOLUTION | Resolved | 2025-03-20 | 2025-05-02 | 253081 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2024-01-05 | 2024-02-02 | 215212 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2021-08-16 | 2021-09-07 | 144209 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2021-04-05 | 2021-05-03 | 136814 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2020-06-24 | 2020-10-13 | 118781 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2017-09-07 | 2017-11-22 | 21209 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2018-01-31 | 2018-05-16 | 37749 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2023-08-23 | 2023-10-06 | 202818 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |